?Starting May 29th, GCT President, Dr. Jeffrey Apter is attending ASCP Annual Meeting in Loews Hotel Miami. The event brings together regulatory specialists from FDA, EMA, NIMH, NIDA, NIAAA and industry key opinion leaders to discuss neuropsychiatric drug development.

?Dr. Apter has over 35 years of experience in CNS clinical trials as a PI and KOL. Do not loose a chance to link up with him in Miami or schedule a meeting in advance by contacting BD department!